Recent News

• 12.01.2025 - Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds
• 07.22.2025 - Kiora Pharmaceuticals Granted U.S. Patent Expanding Protection for KIO-104 in the Treatment of Ocular Disease

Recent Filings

• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.07.2025 - 8-K Current report
• 11.07.2025 - EX-99.1 EX-99.1
• 09.19.2025 - EFFECT Notice of Effectiveness
• 09.15.2025 - S-3 Registration statement under Securities Act of 1933
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - EX-99.1 EX-99.1